Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 133
10
Diseases
337
Unique genes
0.097
Avg. similarity score
Obstructive airway disease
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Obstructive airway disease
Chronic obstructive pulmonary disease
Lung disease
Bronchopulmonary dysplasia
Cystic fibrosis
Pulmonary fibrosis
Emphysema
susceptibility to respiratory infections associated with CD8alpha chain mutation
Genetic generalized epilepsy
lung disease, immunodeficiency, and chromosome breakage syndrome;
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Obstructive airway disease | 7 | 7 | 100 |
| Chronic obstructive pulmonary disease | 5 | 5 | 42 |
| Lung disease | 5 | 5 | 101 |
| Bronchopulmonary dysplasia | 3 | 3 | 45 |
| Cystic fibrosis | 3 | 3 | 62 |
| Pulmonary fibrosis | 3 | 3 | 107 |
| Emphysema | 2 | 2 | 36 |
| susceptibility to respiratory infections associated with CD8alpha chain mutation | 2 | 2 | 1 |
| Genetic generalized epilepsy | 1 | 1 | 1 |
| lung disease, immunodeficiency, and chromosome breakage syndrome; | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SERPINA1 | 6 / 10 | Chronic obstructive pulmonary disease, Cystic fibrosis, Emphysema, Lung disease and 2 more |
| TNF | 6 / 10 | Bronchopulmonary dysplasia, Chronic obstructive pulmonary disease, Cystic fibrosis, Lung disease and 2 more |
| IL1B | 5 / 10 | Bronchopulmonary dysplasia, Cystic fibrosis, Lung disease, Obstructive airway disease and 1 more |
| TGFB1 | 5 / 10 | Chronic obstructive pulmonary disease, Cystic fibrosis, Lung disease, Obstructive airway disease and 1 more |
| GSTM1 | 4 / 10 | Bronchopulmonary dysplasia, Cystic fibrosis, Lung disease, Obstructive airway disease |
| GSTT1 | 4 / 10 | Bronchopulmonary dysplasia, Cystic fibrosis, Lung disease, Obstructive airway disease |
| HMOX1 | 4 / 10 | Chronic obstructive pulmonary disease, Cystic fibrosis, Obstructive airway disease, Pulmonary fibrosis |
| MBL2 | 4 / 10 | Bronchopulmonary dysplasia, Cystic fibrosis, Obstructive airway disease, Pulmonary fibrosis |
| MIF | 4 / 10 | Chronic obstructive pulmonary disease, Cystic fibrosis, Lung disease, Obstructive airway disease |
| MMP9 | 4 / 10 | Chronic obstructive pulmonary disease, Lung disease, Obstructive airway disease, Pulmonary fibrosis |
| PTGS2 | 4 / 10 | Cystic fibrosis, Lung disease, Obstructive airway disease, Pulmonary fibrosis |
| SFTPA1 | 4 / 10 | Bronchopulmonary dysplasia, Lung disease, Obstructive airway disease, Pulmonary fibrosis |
| SFTPB | 4 / 10 | Bronchopulmonary dysplasia, Lung disease, Obstructive airway disease, Pulmonary fibrosis |
| SFTPD | 4 / 10 | Bronchopulmonary dysplasia, Chronic obstructive pulmonary disease, Lung disease, Obstructive airway disease |
| ABCA3 | 3 / 10 | Emphysema, Lung disease, Pulmonary fibrosis |
| ACE | 3 / 10 | Lung disease, Obstructive airway disease, Pulmonary fibrosis |
| ADRB2 | 3 / 10 | Cystic fibrosis, Lung disease, Obstructive airway disease |
| CD8A | 3 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease, susceptibility to respiratory infections associated with CD8alpha chain mutation |
| CFTR | 3 / 10 | Cystic fibrosis, Lung disease, Obstructive airway disease |
| CHRNA5 | 3 / 10 | Emphysema, Lung disease, Obstructive airway disease |
| CXCL2 | 3 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease, Pulmonary fibrosis |
| CYP1A1 | 3 / 10 | Chronic obstructive pulmonary disease, Cystic fibrosis, Obstructive airway disease |
| DSP | 3 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease, Pulmonary fibrosis |
| ELN | 3 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease, Pulmonary fibrosis |
| EPHX1 | 3 / 10 | Chronic obstructive pulmonary disease, Cystic fibrosis, Obstructive airway disease |
| FAM13A | 3 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease, Pulmonary fibrosis |
| GSTP1 | 3 / 10 | Bronchopulmonary dysplasia, Lung disease, Obstructive airway disease |
| HDAC2 | 3 / 10 | Chronic obstructive pulmonary disease, Emphysema, Obstructive airway disease |
| HIF1A | 3 / 10 | Chronic obstructive pulmonary disease, Lung disease, Obstructive airway disease |
| HSPA1A | 3 / 10 | Cystic fibrosis, Obstructive airway disease, Pulmonary fibrosis |
| IL13 | 3 / 10 | Lung disease, Obstructive airway disease, Pulmonary fibrosis |
| IL1RN | 3 / 10 | Bronchopulmonary dysplasia, Obstructive airway disease, Pulmonary fibrosis |
| IL6 | 3 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease, Pulmonary fibrosis |
| NFE2L2 | 3 / 10 | Emphysema, Lung disease, Pulmonary fibrosis |
| NOS2 | 3 / 10 | Chronic obstructive pulmonary disease, Emphysema, Obstructive airway disease |
| NOS3 | 3 / 10 | Chronic obstructive pulmonary disease, Cystic fibrosis, Obstructive airway disease |
| SFTPC | 3 / 10 | Lung disease, Obstructive airway disease, Pulmonary fibrosis |
| SOD3 | 3 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease, Pulmonary fibrosis |
| TNFRSF8 | 3 / 10 | Chronic obstructive pulmonary disease, Emphysema, Obstructive airway disease |
| TP53 | 3 / 10 | Chronic obstructive pulmonary disease, Emphysema, Obstructive airway disease |
| AGER | 2 / 10 | Chronic obstructive pulmonary disease, Cystic fibrosis |
| AGTR2 | 2 / 10 | Cystic fibrosis, Lung disease |
| AP3B1 | 2 / 10 | Lung disease, Pulmonary fibrosis |
| APIP | 2 / 10 | Cystic fibrosis, Lung disease |
| CAT | 2 / 10 | Lung disease, Pulmonary fibrosis |
| CCN2 | 2 / 10 | Lung disease, Pulmonary fibrosis |
| CDKN1A | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| CDKN2A | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| CEBPA | 2 / 10 | Emphysema, Pulmonary fibrosis |
| CEBPB | 2 / 10 | Cystic fibrosis, Pulmonary fibrosis |
| CHRM3 | 2 / 10 | Obstructive airway disease, Pulmonary fibrosis |
| CHRNA3 | 2 / 10 | Lung disease, Obstructive airway disease |
| CRP | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| CSF3 | 2 / 10 | Lung disease, Pulmonary fibrosis |
| CXCL1 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| CXCL8 | 2 / 10 | Chronic obstructive pulmonary disease, Pulmonary fibrosis |
| CYP1A2 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| DEFB1 | 2 / 10 | Lung disease, Obstructive airway disease |
| EDN1 | 2 / 10 | Obstructive airway disease, Pulmonary fibrosis |
| EDNRA | 2 / 10 | Cystic fibrosis, Lung disease |
| EEFSEC | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| EHF | 2 / 10 | Cystic fibrosis, Lung disease |
| FOXO3 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| HGF | 2 / 10 | Lung disease, Pulmonary fibrosis |
| HLA-DPB1 | 2 / 10 | Lung disease, Obstructive airway disease |
| HSPA1B | 2 / 10 | Obstructive airway disease, Pulmonary fibrosis |
| HTR2A | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| ICAM1 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| IL12B | 2 / 10 | Obstructive airway disease, Pulmonary fibrosis |
| IL1A | 2 / 10 | Lung disease, Pulmonary fibrosis |
| KLF12 | 2 / 10 | Bronchopulmonary dysplasia, Emphysema |
| KLF5 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| LCN1 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| MMP14 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| MPO | 2 / 10 | Cystic fibrosis, Lung disease |
| MTCL1 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| MUC4 | 2 / 10 | Cystic fibrosis, Lung disease |
| NAT2 | 2 / 10 | Lung disease, Obstructive airway disease |
| NQO1 | 2 / 10 | Lung disease, Obstructive airway disease |
| NR3C1 | 2 / 10 | Lung disease, Obstructive airway disease |
| NSMCE3 | 2 / 10 | Lung disease, lung disease, immunodeficiency, and chromosome breakage syndrome; |
| PDGFA | 2 / 10 | Lung disease, Pulmonary fibrosis |
| PLAU | 2 / 10 | Emphysema, Pulmonary fibrosis |
| PTX3 | 2 / 10 | Cystic fibrosis, Pulmonary fibrosis |
| RAPGEF3 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| RTEL1 | 2 / 10 | Obstructive airway disease, Pulmonary fibrosis |
| SCGB1A1 | 2 / 10 | Lung disease, Obstructive airway disease |
| SCNN1A | 2 / 10 | Cystic fibrosis, Lung disease |
| SCNN1B | 2 / 10 | Cystic fibrosis, Lung disease |
| SERPINA3 | 2 / 10 | Cystic fibrosis, Obstructive airway disease |
| SERPINE1 | 2 / 10 | Lung disease, Pulmonary fibrosis |
| SLC9A3 | 2 / 10 | Cystic fibrosis, Lung disease |
| TERT | 2 / 10 | Obstructive airway disease, Pulmonary fibrosis |
| TLR4 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| TNFSF8 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| TNK2 | 2 / 10 | Bronchopulmonary dysplasia, Genetic generalized epilepsy |
| TNNT2 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| TRPV4 | 2 / 10 | Chronic obstructive pulmonary disease, Obstructive airway disease |
| VDR | 2 / 10 | Bronchopulmonary dysplasia, Obstructive airway disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Interleukin-4 and Interleukin-13 signaling | Reactome | 33 / 108 | 10.9× | 1.19e-25 | 2.36e-22 ✓ sig. |
| Interleukin-10 signaling | Reactome | 23 / 47 | 17.4× | 8.39e-24 | 1.25e-20 ✓ sig. |
| Pathways in cancer | KEGG | 59 / 533 | 3.9× | 3.89e-20 | 3.05e-17 ✓ sig. |
| Inflammatory bowel disease | KEGG | 20 / 66 | 10.8× | 6.58e-16 | 2.63e-13 ✓ sig. |
| Rheumatoid arthritis | KEGG | 23 / 95 | 8.6× | 1.00e-15 | 3.88e-13 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 27 / 141 | 6.8× | 1.69e-15 | 6.31e-13 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 32 / 216 | 5.3× | 8.34e-15 | 2.65e-12 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 37 / 298 | 4.4× | 1.92e-14 | 5.63e-12 ✓ sig. |
| Chagas disease | KEGG | 22 / 103 | 7.6× | 7.04e-14 | 1.85e-11 ✓ sig. |
| IL-17 signaling pathway | KEGG | 21 / 94 | 8.0× | 1.02e-13 | 2.62e-11 ✓ sig. |
| Legionellosis | KEGG | 16 / 56 | 10.2× | 1.56e-12 | 3.30e-10 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 38 / 361 | 3.8× | 1.62e-12 | 3.43e-10 ✓ sig. |
| HIF-1 signaling pathway | KEGG | 19 / 110 | 6.2× | 1.87e-10 | 2.54e-8 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 18 / 101 | 6.4× | 3.33e-10 | 4.27e-8 ✓ sig. |
| Malaria | KEGG | 13 / 50 | 9.3× | 7.39e-10 | 8.54e-8 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| inflammatory response | GO:0006954 | 53 / 467 | 6.3× | 3.18e-27 | 1.33e-23 ✓ sig. |
| response to hypoxia | GO:0001666 | 30 / 176 | 9.5× | 7.90e-21 | 1.43e-17 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 47 / 504 | 5.2× | 1.45e-20 | 2.58e-17 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 32 / 217 | 8.2× | 3.63e-20 | 6.20e-17 ✓ sig. |
| immune response | GO:0006955 | 48 / 543 | 4.9× | 5.13e-20 | 8.43e-17 ✓ sig. |
| positive regulation of cell migration | GO:0030335 | 36 / 292 | 6.8× | 6.75e-20 | 1.08e-16 ✓ sig. |
| positive regulation of cell population proliferation | GO:0008284 | 46 / 532 | 4.8× | 7.97e-19 | 1.07e-15 ✓ sig. |
| positive regulation of interleukin-8 production | GO:0032757 | 19 / 65 | 16.2× | 2.57e-18 | 3.21e-15 ✓ sig. |
| lung development | GO:0030324 | 22 / 108 | 11.3× | 2.59e-17 | 2.80e-14 ✓ sig. |
| positive regulation of inflammatory response | GO:0050729 | 23 / 122 | 10.5× | 2.98e-17 | 3.18e-14 ✓ sig. |
| positive regulation of tumor necrosis factor production | GO:0032760 | 22 / 113 | 10.8× | 7.21e-17 | 7.13e-14 ✓ sig. |
| positive regulation of MAPK cascade | GO:0043410 | 28 / 224 | 6.9× | 7.25e-16 | 5.83e-13 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 64 / 1,208 | 2.9× | 4.33e-15 | 3.02e-12 ✓ sig. |
| positive regulation of interleukin-6 production | GO:0032755 | 19 / 103 | 10.2× | 2.75e-14 | 1.65e-11 ✓ sig. |
| positive regulation of ERK1 and ERK2 cascade | GO:0070374 | 25 / 201 | 6.9× | 3.05e-14 | 1.82e-11 ✓ sig. |